Paul Alloway - 02 Mar 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Legal Officer and Secretary
Signature
/s/ Paul Alloway
Issuer symbol
QTTB
Transactions as of
02 Mar 2023
Net transactions value
-$15,863
Form type
4
Filing time
06 Mar 2023, 15:05:12 UTC
Previous filing
27 Feb 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Sale $15,863 -10,965 -40% $1.45 16,706 02 Mar 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2022.
F2 This transaction reports the sale of 10,965 shares which were acquired on February 28, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.37 to $1.52. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Remarks:

Chief Legal Officer and Secretary